Summary
Over 250 branded drugs in the U.S. will see price increases starting Jan. 1, 2025, with most hikes below 10% and a median increase of 4.5%.
Key companies like Pfizer, Bristol Myers Squibb, and Sanofi are raising prices on treatments for COVID-19, cancer, and vaccines, citing R&D costs and inflation.
Some prices, such as Merck’s diabetes drugs, will be reduced.
Critics highlight that U.S. drug prices remain the highest globally, while manufacturers face pressure to moderate year-over-year price hikes.
See, this is why “Biden brought down drug prices. For 10 drugs. For Boomers only.” Isn’t a win.
The pharma industry is doing the US public a service by getting people used to paying Trump’s tariffs early.
How we do it in my country.
Kia Ora. This is in one of the yet to rebranded to Woolworths Countdown supermarkets in New Zealand.
I’m back to complain about Australians looking at Medicare through rose tinted glasses, when it still has a lot left to be desired.
PBS is one of the better parts of Medicare, however, there is very often a gap fee, even for PBS medication, unless you qualify for a health care card. Which is great because we’re taking care of people who can’t afford it, and the gap fee is still mostly fine, in most cases.
I mean, look at the sign, has an Asterix right there.
However, the rest of Medicare is more and more resembling a two-tiered system where you get to skip the queue if you have the means to pay, and you get a tax break to do so 👍 and of course, can’t forget our luxury bones which still aren’t covered.
Please do not vote for the LNP, I beg you.
Medicare is not that great compared to what we could afford as one of the richest countries per capita in the world. Only in comparison to the shitshow in the US.
